These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31280219)

  • 1. Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia.
    Kazama S; Kishikawa J; Tanaka T; Hata K; Kawai K; Nozawa H; Ishihara S
    In Vivo; 2019; 33(4):1279-1284. PubMed ID: 31280219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
    BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell markers CD44v9+/CD133- are associated with low apoptosis in both sporadic and ulcerative colitis-associated colorectal cancers.
    Nakagomi E; Mikami T; Funahashi K; Okazumi S; Shibuya K; Hiruta N; Igarashi Y
    Histol Histopathol; 2022 Jun; 37(6):587-595. PubMed ID: 35224715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer.
    Wattanawongdon W; Bathpho TS; Tongtawee T
    Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.
    Fan XS; Wu HY; Yu HP; Zhou Q; Zhang YF; Huang Q
    Int J Colorectal Dis; 2010 May; 25(5):583-90. PubMed ID: 20195621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
    Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
    Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis.
    Kazama S; Kishikawa J; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Watanabe T
    Asian J Surg; 2018 May; 41(3):274-278. PubMed ID: 28190751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
    Xu H; Li J; Chen H; Ghishan FK
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AC133 expression associated with poor prognosis in stage II colorectal cancer.
    Ying X; Wu J; Meng X; Zuo Y; Xia Q; Chen J; Feng Y; Liu R; Li L; Huang W
    Med Oncol; 2013 Mar; 30(1):356. PubMed ID: 23322518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.
    Hsu HC; Liu YS; Tseng KC; Hsu CL; Liang Y; Yang TS; Chen JS; Tang RP; Chen SJ; Chen HC
    Int J Colorectal Dis; 2013 Nov; 28(11):1535-46. PubMed ID: 23784051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.